Concepedia

Matthew Skinner

MS

21

Publications

873

Citations

16

H-Index

1996

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

AstraZeneca (United States)

University of Massachusetts Amherst

AstraZeneca (Sweden)

Roland Hill (United Kingdom)

Matthew Skinner is an author at AstraZeneca (United Kingdom) specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

1996–2021

21

Publications

21

From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients

H‐G Eichler, LG Baird, Richard Barker et al. · Clinical Pharmacology & Therapeutics · 2015 · 184 citations · Full text

Design and optimisation of dendrimer-conjugated Bcl-2/xL inhibitor, AZD0466, with improved therapeutic index for cancer therapy

Claire Patterson, Srividya B. Balachander, Iain Grant et al. · Communications Biology · 2021 · 89 citations · Full text

Studies on the roles of ATP, adenosine and nitric oxide in mediating muscle vasodilatation induced in the rat by acute systemic hypoxia.

Matthew Skinner, Janice M. Marshall · The Journal of Physiology · 1996 · 75 citations · Full text

Can non‐clinical repolarization assays predict the results of clinical thorough QT studies? Results from a research consortium

Eun‐Jung Park, Gary A. Gintant, Daoqin Bi et al. · British Journal of Pharmacology · 2017 · 65 citations · Full text

An Analysis of the Relationship Between Preclinical and Clinical QT Interval-Related Data

Christopher E. Pollard, Matthew Skinner, Stanley E. Lazic et al. · Toxicological Sciences · 2017 · 55 citations · Full text

, , +15

Rows per page

1–5 of 21